216 related articles for article (PubMed ID: 22268103)
21. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.
Wang H; Kohr MJ; Traynham CJ; Ziolo MT
J Mol Cell Cardiol; 2009 Aug; 47(2):304-14. PubMed ID: 19345227
[TBL] [Abstract][Full Text] [Related]
24. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.
Nalli AD; Bhattacharya S; Wang H; Kendig DM; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G330-G341. PubMed ID: 28705807
[TBL] [Abstract][Full Text] [Related]
25. The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems.
Vandendriessche B; Rogge E; Goossens V; Vandenabeele P; Stasch JP; Brouckaert P; Cauwels A
PLoS One; 2013; 8(8):e72155. PubMed ID: 24015214
[TBL] [Abstract][Full Text] [Related]
26. Soluble guanylate cyclase as a novel treatment target for osteoporosis.
Joshua J; Schwaerzer GK; Kalyanaraman H; Cory E; Sah RL; Li M; Vaida F; Boss GR; Pilz RB
Endocrinology; 2014 Dec; 155(12):4720-30. PubMed ID: 25188528
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers.
Frey R; Mück W; Unger S; Artmeier-Brandt U; Weimann G; Wensing G
J Clin Pharmacol; 2008 Dec; 48(12):1400-10. PubMed ID: 18779378
[TBL] [Abstract][Full Text] [Related]
28. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
29. Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice.
Harloff M; Prüschenk S; Seifert R; Schlossmann J
Br J Pharmacol; 2022 Jun; 179(11):2460-2475. PubMed ID: 33651375
[TBL] [Abstract][Full Text] [Related]
30. Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI/PET imaging.
Methner C; Buonincontri G; Hu CH; Vujic A; Kretschmer A; Sawiak S; Carpenter A; Stasch JP; Krieg T
PLoS One; 2013; 8(12):e83910. PubMed ID: 24391843
[TBL] [Abstract][Full Text] [Related]
31. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
32. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
Gorbe A; Giricz Z; Szunyog A; Csont T; Burley DS; Baxter GF; Ferdinandy P
Basic Res Cardiol; 2010 Sep; 105(5):643-50. PubMed ID: 20349314
[TBL] [Abstract][Full Text] [Related]
33. Beetroot juice reduces infarct size and improves cardiac function following ischemia-reperfusion injury: Possible involvement of endogenous H2S.
Salloum FN; Sturz GR; Yin C; Rehman S; Hoke NN; Kukreja RC; Xi L
Exp Biol Med (Maywood); 2015 May; 240(5):669-81. PubMed ID: 25361774
[TBL] [Abstract][Full Text] [Related]
34. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
36. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway.
Wang Q; Liu HR; Mu Q; Rose P; Zhu YZ
J Cardiovasc Pharmacol; 2009 Aug; 54(2):139-46. PubMed ID: 19546814
[TBL] [Abstract][Full Text] [Related]
37. Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.
Hoffmann LS; Kretschmer A; Lawrenz B; Hocher B; Stasch JP
PLoS One; 2015; 10(12):e0145048. PubMed ID: 26717150
[TBL] [Abstract][Full Text] [Related]
38. Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.
Nagasaka Y; Buys ES; Spagnolli E; Steinbicker AU; Hayton SR; Rauwerdink KM; Brouckaert P; Zapol WM; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1477-83. PubMed ID: 21257915
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
40. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
